Register Login

KALARIS THERAPEUTICS, INC. (KLRS)

SymbolKLRS
NameKALARIS THERAPEUTICS, INC.
SectorHEALTH CARE
RegionNorth America
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
Address1100 WINTER STREET,SUITE 500, WALTHAM, Massachusetts, 02451, United States
Telephone+1 212 915 2577
Fax—
Email—
Websitehttps://www.kalaristx.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK0001754068
Description

Kalaris was founded by experienced leaders in ophthalmology drug development and commercialization to address a major unmet need in the treatment of retinal diseases.Existing therapies for retinal neovascular / exudative diseases have made great strides in preserving or improving vision, but they require frequent clinic visits over many years that place a significant burden on patients and caregivers. This onerous visit regimen often leads to missed or delayed injections and suboptimal patient outcomes.

Additional info from NASDAQ:
Kalaris was founded by experienced leaders in ophthalmology drug development and commercialization to address a major unmet need in the treatment of retinal diseases.Existing therapies for retinal neovascular / exudative diseases have made great strides in preserving or improving vision, but they require frequent clinic visits over many years that place a significant burden on patients and caregivers. This onerous visit regimen often leads to missed or delayed injections and suboptimal patient outcomes.

2026-05-12 12:08

(30% Negative) KALARIS THERAPEUTICS, INC. (KLRS) Reports Q2 2026 Financial Results

Read more
2026-04-24 17:28

New Form ARS - Kalaris Therapeutics, Inc. <b>Filed:</b> 2026-04-24 <b>AccNo:</b> 0001193125-26-177387 <b>Size:</b> 2 MB

Read more
2026-04-24 17:27

New Form DEFA14A - Kalaris Therapeutics, Inc. <b>Filed:</b> 2026-04-24 <b>AccNo:</b> 0001193125-26-177383 <b>Size:</b> 536 KB

Read more
2026-04-24 17:25

New Form DEF 14A - Kalaris Therapeutics, Inc. <b>Filed:</b> 2026-04-24 <b>AccNo:</b> 0001193125-26-177362 <b>Size:</b> 5 MB

Read more
2026-04-14 07:03

New Form EFFECT - Kalaris Therapeutics, Inc. <b>Filed:</b> 2026-04-13 <b>AccNo:</b> 9999999995-26-001176 <b>Size:</b> 1 KB

Read more
2026-04-14 07:03

New Form EFFECT - Kalaris Therapeutics, Inc. <b>Filed:</b> 2026-04-13 <b>AccNo:</b> 9999999995-26-001175 <b>Size:</b> 1 KB

Read more
2026-04-13 17:19

New Form 424B3 - Kalaris Therapeutics, Inc. <b>Filed:</b> 2026-04-13 <b>AccNo:</b> 0001193125-26-152904 <b>Size:</b> 211 KB

Read more
2026-04-13 17:19

New Form 424B3 - Kalaris Therapeutics, Inc. <b>Filed:</b> 2026-04-13 <b>AccNo:</b> 0001193125-26-152902 <b>Size:</b> 180 KB

Read more
2026-04-10 20:02

(99% Neutral) KALARIS THERAPEUTICS, INC. (KLRS) Announces New Board Appointment

Read more
2026-04-03 17:20

New Form S-3 - Kalaris Therapeutics, Inc. <b>Filed:</b> 2026-04-03 <b>AccNo:</b> 0001193125-26-142199 <b>Size:</b> 1 MB

Read more